Onkure Therapeutics, Inc. · NASDAQ:OKUR
AI Biotechnology LLC reported a 19.99% stake in Onkure Therapeutics, Inc. (Schedule 13D)
Event Mar 31, 2026 · Filed Apr 7, 2026
AI Biotechnology LLC reported a 19.99% stake in Onkure Therapeutics, Inc., 9,091,532 shares, with active intent on Mar 31, 2026. Filed Apr 7, 2026 (Schedule 13D).
- Stake
- 19.99%
- Shares
- 9,091,532
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| AI Biotechnology LLC | 19.99% | 9,091,532 |
| Access Industries Holdings LLC | 19.99% | 9,091,532 |
| Access Industries Management, LLC | 19.99% | 9,091,532 |
| Len Blavatnik | 19.99% | 9,091,532 |
Source
Related
- Onkure Therapeutics, Inc.
- AI Biotechnology LLC
- Onkure Therapeutics, Inc. shareholders
- Schedule 13G · Coastlands Capital LP · Oct 7, 2026
- Form 4 · Saccomano Nicholas A · Sep 23, 2026
- Form 4 · Leverone Jason A. · Sep 23, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026